A self-test is a procedure that can be carried out at home to identify or diagnose a variety of illnesses. The terms "home test," "at-home test," and "over-the-counter (OTC) test" are also used to describe it. In order to protect everyone by reducing the likelihood of viral transmission, self-tests can also be used as one of many risk-reduction strategies, such as vaccination, masking, and physical separation. New methods for identifying, tracking, and treating patients and their conditions are being made possible thanks to self-testing. These testing kits are being created as a component of a continuum of preventative and wellness initiatives, from the diagnosis of acute infections to the treatment of chronic conditions to the identification of potential health issues. These tests are used for a variety of purposes, including glucose monitoring, checking for vitamin and mineral deficiencies, hormone testing, checking for pregnancy, and other things. Key market players are focusing on developing and launching new self-test kits for emerging diseases and infections such as the COVID-19.
For instance, on July 12, 2021, Abbott, an American multinational medical devices and health care company announced the launch of Panbio COVID-19 Antigen Self-Test for the detection of the SARS-CoV-2 virus in adults and children with or without symptoms.
Market Dynamics
Major companies operating in the global self-testing market are focused on product launches or approvals, which is expected to drive the market growth of global self-testing market over the forecast period. For instance, in April 2021, Lucira Health, Inc., a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, announced that Health Canada approved the company's LUCIRA CHECK IT COVID-19 test kit. The LUCIRA CHECK IT COVID-19 test kit is the first Health Canada-approved self-test for people with or without symptoms.
Key features of the study:
- This report provides an in-depth analysis of the global self-testing market, market size (US$ Billion), and compound annual growth rate (CAGR %) for the forecast period (2024-2031), considering 2023 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted By key players
- It profiles key players in the global self-testing market based on the following parameters – company highlights, types portfolio, key highlights, financial performance, and market strategies
- Key companies covered as a part of this study include Becton, Dickinson and Company, Abbott, ACCESS BIO, CELLTRION INC., Siemens Healthcare GmbH, ACON Laboratories Inc., ARKRAY, Inc, Hoffmann-La Roche Ltd., OraSure Technologies Inc., Quest Diagnostics, Bionime Corporation, Btnx Inc. iHealth Labs Inc., InBios International, Inc. USA. and True Diagnostics Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global self-testing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global self-testing market
Detailed Segmentation:
- Global Self-Testing market, By Product Type
- Kits
- Self-testing kits
- Self-collection kits
- Self-testing Devices
- Global Self-Testing market, By Application Type
- Blood Glucose Testing
- Pregnancy Testing
- Pulmonary Function Testing
- Urinary Tract Infection Testing
- Sexually transmitted infections (STIs) Testing
- Genetic Testing
- Vitamin and Mineral Deficiency Testing
- COVID Testing
- Allergy Testing
- Gastrointestinal Screening
- Hormone Testing
- Food Sensitivity Testing
- Others (Infectious Disease Testing, etc.)
- Global Self-Testing market, By Sample Type
- Blood Sample
- Saliva Sample
- Nasal Sample
- Stool Sample
- Urine Sample
- Other Sample (Vaginal Swab Sample and Breathe Sample)
- Global Self-Testing market, By Test Type
- Laboratory Tests
- Point of Care Tests/Homecare Tests
- Global Self-Testing market, By Distribution Channel
- Offline
- Hospital Pharmacies
- Retail Pharmacies/ Drug Stores
- Supermarkets and Hypermarket
- Online
- Global Self-Testing Market, By Region:
- North America
- Latin America
- By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- By Country
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- By Country
- GCC
- Israel
- Rest of Middle East
- Africa
- By Country/Region
- South Africa
- Central Africa
- North Africa
- Company Profiles
- Becton, Dickinson and Company*
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Abbott
- ACCESS BIO
- CELLTRION INC.
- Siemens Healthcare GmbH
- ACON Laboratories, Inc.
- ARKRAY, Inc
- F. Hoffmann-La Roche Ltd.
- OraSure Technologies Inc.
- Quest Diagnostics
- Bionime Corporation
- Btnx Inc.
- iHealth Labs Inc.
- True Diagnostics Inc.
- InBios International, Inc. USA.
“*” marked represents similar segmentation in other categories in the respective section.
